Publication | Open Access
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer
135
Citations
22
References
2023
Year
ClinicalTrials.gov Identifier: NCT03639948.
| Year | Citations | |
|---|---|---|
Page 1
Page 1